Reduced Dose Intensities of Doxorubicin in Elderly Patients with DLBCL in Rituximab Era

PURPOSE: The dose intensity of doxorubicin (DID) is important to the survival of diffuse large B cell lymphoma (DLBCL) patients. However, due to expected toxicities, most elderly patients cannot receive full doses of anthracyclines. The purpose of this study was to evaluate the effect of DID on the...

Descripción completa

Detalles Bibliográficos
Autores principales: Ha, Hyerim, Keam, Bhumsuk, Kim, Tae Min, Jeon, Yoon Kyung, Lee, Se-Hoon, Kim, Dong-Wan, Kim, Chul Woo, Heo, Dae Seog
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4720063/
https://www.ncbi.nlm.nih.gov/pubmed/25865654
http://dx.doi.org/10.4143/crt.2014.339

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4720063/
https://www.ncbi.nlm.nih.gov/pubmed/25865654
http://dx.doi.org/10.4143/crt.2014.339

Ejemplares similares